Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort | Zendy

Matthew R. Cooperberg | Zendy; Jeffry Simko | Zendy; Janet E. Cowan | Zendy; Julia Reid | Zendy; Azita Djalilvand | Zendy; S. K. Bhatnagar | Zendy; Alexander Gutin | Zendy; Jerry S. Lanchbury | Zendy; Gregory P. Swanson | Zendy; Steven Stone | Zendy; Peter R. Carroll | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort

Author(s) -

Matthew R. Cooperberg,

Jeffry Simko,

Janet E. Cowan,

Julia Reid,

Azita Djalilvand,

S. K. Bhatnagar,

Alexander Gutin,

Jerry S. Lanchbury,

Gregory P. Swanson,

Steven Stone,

Peter R. Carroll

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.46.4396

Subject(s) - medicine , capra , prostatectomy , nomogram , cohort , concordance , prostate cancer , hazard ratio , framingham risk score , biochemical recurrence , proportional hazards model , oncology , prostate specific antigen , receiver operating characteristic , urology , cancer , disease , confidence interval , biology , ecology

We aimed to validate a previously described genetic risk score, denoted the cell-cycle progression (CCP) score, in predicting contemporary radical prostatectomy (RP) outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research